258 related articles for article (PubMed ID: 25246568)
1. The cardiac-specific N-terminal region of troponin I positions the regulatory domain of troponin C.
Hwang PM; Cai F; Pineda-Sanabria SE; Corson DC; Sykes BD
Proc Natl Acad Sci U S A; 2014 Oct; 111(40):14412-7. PubMed ID: 25246568
[TBL] [Abstract][Full Text] [Related]
2. Dilated Cardiomyopathy Mutations and Phosphorylation disrupt the Active Orientation of Cardiac Troponin C.
Mahmud Z; Dhami PS; Rans C; Liu PB; Hwang PM
J Mol Biol; 2021 Jun; 433(13):167010. PubMed ID: 33901537
[TBL] [Abstract][Full Text] [Related]
3. Binding of cardiac troponin-I147-163 induces a structural opening in human cardiac troponin-C.
Li MX; Spyracopoulos L; Sykes BD
Biochemistry; 1999 Jun; 38(26):8289-98. PubMed ID: 10387074
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation and mutation of human cardiac troponin I deferentially destabilize the interaction of the functional regions of troponin I with troponin C.
Li MX; Wang X; Lindhout DA; Buscemi N; Van Eyk JE; Sykes BD
Biochemistry; 2003 Dec; 42(49):14460-8. PubMed ID: 14661957
[TBL] [Abstract][Full Text] [Related]
5. Structure and function of cardiac troponin C (TNNC1): Implications for heart failure, cardiomyopathies, and troponin modulating drugs.
Li MX; Hwang PM
Gene; 2015 Oct; 571(2):153-66. PubMed ID: 26232335
[TBL] [Abstract][Full Text] [Related]
6. Structure of the regulatory N-domain of human cardiac troponin C in complex with human cardiac troponin I147-163 and bepridil.
Wang X; Li MX; Sykes BD
J Biol Chem; 2002 Aug; 277(34):31124-33. PubMed ID: 12060657
[TBL] [Abstract][Full Text] [Related]
7. The Role of Electrostatics in the Mechanism of Cardiac Thin Filament Based Sensitizers.
Cai F; Robertson IM; Kampourakis T; Klein BA; Sykes BD
ACS Chem Biol; 2020 Aug; 15(8):2289-2298. PubMed ID: 32633482
[TBL] [Abstract][Full Text] [Related]
8. Structural and functional consequences of the cardiac troponin C L48Q Ca(2+)-sensitizing mutation.
Wang D; Robertson IM; Li MX; McCully ME; Crane ML; Luo Z; Tu AY; Daggett V; Sykes BD; Regnier M
Biochemistry; 2012 Jun; 51(22):4473-87. PubMed ID: 22591429
[TBL] [Abstract][Full Text] [Related]
9. Defining the binding site of levosimendan and its analogues in a regulatory cardiac troponin C-troponin I complex.
Robertson IM; Baryshnikova OK; Li MX; Sykes BD
Biochemistry; 2008 Jul; 47(28):7485-95. PubMed ID: 18570382
[TBL] [Abstract][Full Text] [Related]
10. Solution structures of the C-terminal domain of cardiac troponin C free and bound to the N-terminal domain of cardiac troponin I.
Gasmi-Seabrook GM; Howarth JW; Finley N; Abusamhadneh E; Gaponenko V; Brito RM; Solaro RJ; Rosevear PR
Biochemistry; 1999 Jun; 38(26):8313-22. PubMed ID: 10387077
[TBL] [Abstract][Full Text] [Related]
11. Effects of T142 phosphorylation and mutation R145G on the interaction of the inhibitory region of human cardiac troponin I with the C-domain of human cardiac troponin C.
Lindhout DA; Li MX; Schieve D; Sykes BD
Biochemistry; 2002 Jun; 41(23):7267-74. PubMed ID: 12044157
[TBL] [Abstract][Full Text] [Related]
12. Solution structure of the regulatory domain of human cardiac troponin C in complex with the switch region of cardiac troponin I and W7: the basis of W7 as an inhibitor of cardiac muscle contraction.
Oleszczuk M; Robertson IM; Li MX; Sykes BD
J Mol Cell Cardiol; 2010 May; 48(5):925-33. PubMed ID: 20116385
[TBL] [Abstract][Full Text] [Related]
13. Modulation of cardiac troponin C function by the cardiac-specific N-terminus of troponin I: influence of PKA phosphorylation and involvement in cardiomyopathies.
Baryshnikova OK; Li MX; Sykes BD
J Mol Biol; 2008 Jan; 375(3):735-51. PubMed ID: 18042489
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation-dependent conformational transition of the cardiac specific N-extension of troponin I in cardiac troponin.
Howarth JW; Meller J; Solaro RJ; Trewhella J; Rosevear PR
J Mol Biol; 2007 Oct; 373(3):706-22. PubMed ID: 17854829
[TBL] [Abstract][Full Text] [Related]
15. Interaction of levosimendan with cardiac troponin C in the presence of cardiac troponin I peptides.
Sorsa T; Pollesello P; Permi P; Drakenberg T; Kilpeläinen I
J Mol Cell Cardiol; 2003 Sep; 35(9):1055-61. PubMed ID: 12967628
[TBL] [Abstract][Full Text] [Related]
16. A structural and functional perspective into the mechanism of Ca2+-sensitizers that target the cardiac troponin complex.
Robertson IM; Sun YB; Li MX; Sykes BD
J Mol Cell Cardiol; 2010 Dec; 49(6):1031-41. PubMed ID: 20801130
[TBL] [Abstract][Full Text] [Related]
17. Interaction of cardiac troponin C with calmodulin antagonist [corrected] W7 in the presence of three functional regions of cardiac troponin I.
Li MX; Hoffman RM; Sykes BD
Biochemistry; 2006 Aug; 45(32):9833-40. PubMed ID: 16893183
[TBL] [Abstract][Full Text] [Related]
18. Structure of the Mg2+-loaded C-lobe of cardiac troponin C bound to the N-domain of cardiac troponin I: comparison with the Ca2+-loaded structure.
Finley NL; Howarth JW; Rosevear PR
Biochemistry; 2004 Sep; 43(36):11371-9. PubMed ID: 15350124
[TBL] [Abstract][Full Text] [Related]
19. The dilated cardiomyopathy G159D mutation in cardiac troponin C weakens the anchoring interaction with troponin I.
Baryshnikova OK; Robertson IM; Mercier P; Sykes BD
Biochemistry; 2008 Oct; 47(41):10950-60. PubMed ID: 18803402
[TBL] [Abstract][Full Text] [Related]
20. Energetics of the induced structural change in a Ca2+ regulatory protein: Ca2+ and troponin I peptide binding to the E41A mutant of the N-domain of skeletal troponin C.
McKay RT; Saltibus LF; Li MX; Sykes BD
Biochemistry; 2000 Oct; 39(41):12731-8. PubMed ID: 11027154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
